These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16257)

  • 1. [Emergency problems of the graft vs host reaction (literature survey)].
    Shevelev AS
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):35-41. PubMed ID: 16257
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 4. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
    Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of suppressor cells in transplantation tolerance.
    Tutschka PJ; Santos GW; Beschorner W
    Transplant Proc; 1979 Mar; 11(1):882-6. PubMed ID: 156436
    [No Abstract]   [Full Text] [Related]  

  • 6. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 7. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of stable graft-host tolerance in canine and human radiation chimeras.
    Storb R; Tsoi MS; Weiden PL; Graham TC; Thomas ED
    Transplant Proc; 1976 Dec; 8(4):561-4. PubMed ID: 11587
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous mixed lymphocyte reaction in man. XII. Deficiency of the autologous mixed lymphocyte reaction in patients undergoing allogeneic bone marrow transplantation. Relationship with chronic graft-versus-host disease.
    Gupta S; Kapoor N; O'Reilly R; Good RA
    J Clin Lab Immunol; 1984 Aug; 14(4):173-5. PubMed ID: 6238167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation: introduction.
    Mathé G; Oldham R
    Transplant Proc; 1974 Dec; 6(4):333-4. PubMed ID: 4155149
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tissue typing before bone marrow transplantation].
    Kosinski S
    Postepy Hig Med Dosw; 1979; 33(3):221-38. PubMed ID: 42045
    [No Abstract]   [Full Text] [Related]  

  • 13. Vascularized bone marrow transplantation (VBMT): induction of stable mixed T-cell chimerism and transplantation tolerance in unmodified recipients.
    Yazdi B; Patel MP; Ramsamooj R; Llull R; Achauer BM; Black KS; Hewitt CW
    Transplant Proc; 1991 Feb; 23(1 Pt 1):739-40. PubMed ID: 1990672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological concepts relating to organ transplantation].
    Dei Poli G; Massa G; Rosso PA; Dei Poli N
    Minerva Chir; 1980 Jun; 35(11):829-78. PubMed ID: 6450338
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
    Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
    J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veto cells are not responsible for alloimmunization-induced abrogation of lethal graft-versus-host reaction.
    Halle-Pannenko O; Bruley-Rosset M; Pritchard LL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):549-50. PubMed ID: 2978923
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical aspects of the graft-versus host disease (author's transl)].
    Górski A
    Przegl Lek; 1977; 34(12):861-4. PubMed ID: 24236
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.
    Good RA
    Birth Defects Orig Artic Ser; 1975; 11(1):377-9. PubMed ID: 238679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.